Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials-Reference-Cited by-同舟云学术

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials

Published:2014-10 Issue:1 Volume:1 Page:e37-e46
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Prins Martin H,Lensing Anthonie W A,Brighton Tim A,Lyons Roger M,Rehm Jeffrey,Trajanovic Mila,Davidson Bruce L,Beyer-Westendorf Jan,Pap Ákos F,Berkowitz Scott D,Cohen Alexander T,Kovacs Michael J,Wells Philip S,Prandoni Paolo

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. Oral rivaroxaban for symptomatic venous thromboembolism;N Engl J Med,2010

2. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism;N Engl J Med,2012

3. Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism;Prins;Thromb J,2013

4. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies;Prins;Thromb J,2013

5. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial;Büller;Ann Intern Med,2004

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants;American Journal of Cardiovascular Drugs;2024-09-06

2. Deep venous thrombosis (DVT) diagnostics: gleaning insights from point-of-care ultrasound (PoCUS) techniques in emergencies: a systematic review and meta-analysis;The Ultrasound Journal;2024-07-30

3. Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial;Research and Practice in Thrombosis and Haemostasis;2024-07

4. Evaluation of acute thrombus regression effect of edoxaban for deep vein thrombosis in patients with cancer: a single-center prospective observational study;Heart and Vessels;2024-05-21

5. The role of direct oral anticoagulants in cancer-associated thrombosis. Review of clinical guidelines and real practice;Journal of Modern Oncology;2024-03-05